Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

Pediatrics

Volumn 111, Issue 1, 2003, Pages 179-185

  Wilens, Timothy E ^a   Faraone, Stephen V ^a   Biederman, Joseph ^a   Gunawardene, Samantha ^a  

^a NONE

Author keywords

Attention deficit hyperactivity disorder; Pharmacotherapy; Substance use

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; METHYLPHENIDATE;

ALCOHOL ABUSE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; DRUG EFFECT; FOLLOW UP; HUMAN; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 0037227127     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.111.1.179     Document Type: Review

References (56)

1. Anderson JC, Williams S, McGee R, Silva PA. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987;44:69-76
2. Bird HR, Gould MS, Staghezza BM. Patterns of psychiatric comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry. 1993;32:361-368
3. Goldman L, Genel M, Bezman R, Slanetz P. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 1998;279:1100-1107
4. Greenhill L, Osman B. Ritalin: Theory and Practice. New York, NY: Mary Ann Liebert; 1999
5. Swanson J, McBurnett K, Christian D, Wigal T. Stimulant medications and the treatment of children with ADHD. In: Ollendick T, Prinz R, eds. Advances in Clinical Psychology. New York, NY: Plenum Press; 1995:265-322
6. Wilens T, Spencer T. The stimulants revisited. Child Adolesc Psychiatric Clin North Am. 2000;9:573-603
7. Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996;35:409-432
8. Group MTS. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56:1073-1086
9. Drug Enforcement Administration. Methylphenidate Review Document. Washington, DC: Office of Diversion Control, Drug and Chemical Evaluation Section; 1995
10. Vitiello B. Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001;11:25-34
11. Kollins SH, MacDonald EK, Cush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav. 2001;68:611-627
12. Schenk S, Davidson E. Stimulant preexposure sensitizes rats and humans to the rewarding effects of cocaine. NIDA Res Monogr. 1998;169:56-82
13. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993;18:247-291
14. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2). Available at: www.pediatrics.org/cgi/content/full/104/2/e20
15. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil. 1998;31:533-544
16. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4:231-244
17. Faraone SV, Simpson JC, Brown WA. Mathematical models of complex dose-response relationships: implications for experimental design in psychopharmacologic research. Stat Med. 1992;11:685-702
18. Carlin JB. Meta-analysis for 2 × 2 tables: a Bayesian approach. Stat Med. 1992;11:141-158
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634
20. Stata Corporation. Stata Reference Manual: Release 6.0. College Station, TX: Stata Corporation; 1999
21. Molina B, Pelham W, Roth J. Stimulant medication and substance use by adolescents with a childhood history of ADHD. Poster at the Biennial Meeting of the International Society for Research in Child and Adolescent Psychopathology; Barcelona, Spain; June 1999
22. Wilens T. Attention deficit hyperactivity disorder and substance use disorders - the nature of the relationship, subtypes at risk, and treatment issues. In: Jensen PS, Cooper J, eds. Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. Kingston, NJ: Civic Research Institute; 2002:1-17
23. Lambert N. Stimulant treatment as a risk factor for nicotine and substance abuse. In: Jensen PS, Cooper J, eds. Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. Kingston, NJ: Civic Research Institute; 2002:1-24
24. Paternite CE, Loney J, Salisbury H, Whaley MA. Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacol. 1999;9:169-184
25. Loney J, Kramer JR, Salisbury H. Medicated versus unmedicated ADHD children: adult involvement with legal and illegal drugs. In: Jensen PS, Cooper J, eds. Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. Kingston, NJ: Civic Research Institute; 2002:1-16
26. Huss M. ADHD and substance abuse. In: IX Annual European Congress of Psychiatry. Hamburg, Germany; 1999
27. Loney J, Klahn M, Kosier T, Conboy J. Hyperactive boys and their brothers at 21: predictors of aggressive and antisocial outcomes. In: van Dused KT, Mednick SA, eds. Prospective Studies of Crime and Delinquency. Hingham, MA: Kluwere/Nijhoff; 1982:181-207
28. Kramer J, Loney J, Whaley-Klahn M. The role of prescribed medication in hyperactive youths' substance use. Poster presented at the American Psychological Association; Los Angeles, CA; August 1981
29. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148:564-577
30. Mannuzza S, Gittelman-Klein R, Konig PH, Giampino TL. Hyperactive boys almost grown up: IV. Criminality and its relationship to psychiatric status. Arch Gen Psychiatry. 1989;46:1073-1079
31. Mannuzza S, Klein RG, Bonagura N, et al. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry. 1991;48:77-83
32. Hechtman L, Weiss G. Controlled prospective fifteen year follow-up of hyperactives as adults: non-medical drug and alcohol use and antisocial behaviour. Can J Psychiatry. 1986;31:557-567
33. Biederman J, Wilens T, Mick E, et al. Is ADHD a risk for psychoactive substance use disorder? Findings from a four year follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36:21-29
34. Volkow ND, Ding Y, Fowler JS, et al. Is methylphenidate like cocaine? Arch Gen Psychiatry. 1995;52:456-463
35. Volkow ND, Wang GJ, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in human brain. J Neurosci. 2001;21:RC121
36. Gerasimov M, Franceschi M, Volkow ND, et al. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther. 2000;295:51-57
37. Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997;89:480-487
38. Laufer MW, Denhoff E. Hyperkinetic behavior syndrome in children. J Pediatr. 1957;50:463-474
39. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis. 1997;185:475-482
40. Chilcoat HD, Breslau N. Pathways from ADHD to early drug use. J Am Acad Child Adolesc Psychiatry. 1999;38:1347-1354
41. Milberger S, Biederman J, Faraone S, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry, 1997;36:37-43
42. Pomerleau O, Downey K, Stelson F, Pomerleau C. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse. 1995;7:373-378
43. Weiss G. Attention-Deficit Hyperactivity Disorder. Philadelphia, PA: WB Saunders Company; 1992
44. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50:565-576
45. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150:1792-1798
46. Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. Am J Public Health. 1984;74:673-681
47. Kandel DB, Logan JA. Patterns of drug use from adolescence to young adulthood: I. Periods of risk for initiation, continued use, and discontinuation. Am J Public Health. 1984;74:660-666
48. Crum RM, Bucholz KK, Helzer JE, Anthony JC. The risk of alcohol abuse and dependence in adulthood: the association with educational level. Am J Epidemiol. 1992;135:989-999
49. Brook JS, Whiteman M, Cohen P, Shapiro J, Balka E. Longitudinally predicting late adolescent and young adult drug use: childhood and adolescent precursors. J Am Acad Child Adolesc Psychiatry. 1995;34:1230-1238
50. Klein R, Abikoff H, Klass E, et al. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1997;54:1073-1080
51. Weiss G, Hechtman L, Milroy T, Perlman T. Psychiatric status of hyperactives as adults: a controlled prospective 15 year followup of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry. 1985;24:211-220
52. Biederman J, Wilens TE, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995;152:1652-1658
53. Disney ER, Elkins IJ, McGue M, Iacono WG. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry. 1999;156:1515-1521
54. Faraone SV, Biederman J, Mick E, et al. Family study of girls with attention deficit hyperactivity disorder. Am J Psychiatry. 2000;157:1077-1083
55. Levin FR, Kleber HD. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv Rev Psychiatry. 1995;2:246-258
56. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000;61:244-251